Thyme Care Secures $97M Series D to Expand AI-Driven Oncology Solutions

September 25, 2025
Thyme Care has raised $97 million in a Series D funding round, backed by strategic investors including CVS Health Ventures and JPMorgan Chase, to enhance its AI-driven oncology care solutions.

Thyme Care has announced a $97 million Series D funding round, backed by strategic investors such as CVS Health Ventures and JPMorgan Chase, announced in a press release. This funding brings Thyme Care's total capital raised to $275 million.

The company, which manages over $5 billion in oncology spending and serves 8 million people nationwide, aims to dismantle barriers in cancer care through an AI orchestration layer. This technology reduces cognitive overload on care teams and accelerates stakeholder integration, providing timely and personalized support to patients.

With new contracts in Medicare, commercial, and employer sectors, Thyme Care is positioned to expand its national scale and improve outcomes in oncology care. The funding will support the company's mission to build an integrated oncology infrastructure focused on value, accountability, and enhancing patient experiences.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

09/25
Burnt Secures $3.8M to Automate Food Supply Chains with AI
09/25
NAVER D2SF Invests in GravityLabs for Health Habit Platform Expansion
09/25
Beroe Secures $34 Million to Enhance Procurement Intelligence
09/24
Cohere Secures Additional $100 Million, Valuation Hits $7 Billion
09/24
epresspack Acquires TheNewsMarket to Expand Global Presence

More from: Life Sciences

09/25
RamSoft Integrates Koios AI for Enhanced Cancer Diagnosis
09/25
Infinitus Systems Introduces MCP Server for Healthcare AI Interoperability
09/25
Avant Technologies Enters Longevity Biotech with Klothonova Joint Venture
09/25
Digital Pathology Market to Reach $3.86 Billion by 2033
09/25
Radicle Science Expands Leadership Team with New Executive Appointments

Subscribe to AI Funding Brief

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like